Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.
作者信息
Keating Nancy L, O'Malley A James, Freedland Stephen J, Smith Matthew R
出版信息
J Natl Cancer Inst. 2012 Oct 3;104(19):1518-23. doi: 10.1093/jnci/djs376.
Abstract
摘要
相似文献
1
Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.
J Natl Cancer Inst. 2012 Oct 3;104(19):1518-23. doi: 10.1093/jnci/djs376.
2
Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.
J Natl Cancer Inst. 2010 Jan 6;102(1):39-46. doi: 10.1093/jnci/djp404. Epub 2009 Dec 7.
3
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.
J Clin Oncol. 2006 Sep 20;24(27):4448-56. doi: 10.1200/JCO.2006.06.2497.
4
[Cardiovascular risks of androgen deprivation therapy for prostate cancer].
Urologe A. 2016 May;55(5):627-31. doi: 10.1007/s00120-015-0021-1.
5
Does the benefit justify the risk?
J Natl Cancer Inst. 2010 Jan 6;102(1):4-5. doi: 10.1093/jnci/djp427. Epub 2009 Dec 7.
6
Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism.
Eur Urol. 2012 Jun;61(6):1119-28. doi: 10.1016/j.eururo.2012.01.045. Epub 2012 Feb 1.
7
Risk of Cardiovascular Ischemic Events After Surgical Castration and Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer: A Nationwide Cohort Study.
J Clin Oncol. 2017 Nov 10;35(32):3697-3705. doi: 10.1200/JCO.2016.71.4204. Epub 2017 Oct 2.
8
The impact of androgen-deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non-metastatic prostate cancer: a population-based study.
BJU Int. 2014 Dec;114(6b):E82-E89. doi: 10.1111/bju.12732. Epub 2014 Jul 27.
9
Is hormone ablation still the right choice for advanced prostate cancer?
BJU Int. 2007 Jul;100 Suppl 2:36-9. doi: 10.1111/j.1464-410X.2007.06952.x.
10
Comparison of Gonadotropin-Releasing Hormone Agonists and Orchiectomy: Effects of Androgen-Deprivation Therapy.
JAMA Oncol. 2016 Apr;2(4):500-7. doi: 10.1001/jamaoncol.2015.4917.
引用本文的文献
1
National survey of radiotherapy and androgen deprivation therapy strategies with PSMA-PET/CT integration in intermediate-risk prostate cancer: TROD 09-007 study.
Can J Urol. 2025 Aug 29;32(4):243-254. doi: 10.32604/cju.2025.066700.
2
Taiwan Consensus for the Management of Cardiovascular Risks and Complications in Patients with Prostate Cancer.
Acta Cardiol Sin. 2025 May;41(3):288-310. doi: 10.6515/ACS.202505_41(3).20250224A.
3
The impact of age on clinicopathological features and treatment results in patients with localised prostate cancer receiving definitive radiotherapy.
Acta Oncol. 2024 Nov 5;63:858-866. doi: 10.2340/1651-226X.2024.40759.
4
Androgen-deprivation therapy with leuprolide increases abdominal adiposity without causing cardiac dysfunction in middle-aged male mice: effect of sildenafil.
Am J Physiol Regul Integr Comp Physiol. 2023 Apr 1;324(4):R589-R600. doi: 10.1152/ajpregu.00259.2022. Epub 2023 Mar 6.
5
Interaction between gut microbiota and sex hormones and their relation to sexual dimorphism in metabolic diseases.
Biol Sex Differ. 2023 Feb 7;14(1):4. doi: 10.1186/s13293-023-00490-2.
6
UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies.
Can Urol Assoc J. 2022 Aug;16(8):E416-E431. doi: 10.5489/cuaj.8054.
7
Does Androgen Deprivation for Prostate Cancer Affect Normal Adaptation to Resistance Exercise?
Int J Environ Res Public Health. 2022 Mar 23;19(7):3820. doi: 10.3390/ijerph19073820.
8
Association between Androgen Deprivation Therapy and the Risk of Inflammatory Rheumatic Diseases in Men with Prostate Cancer: Nationwide Cohort Study in Lithuania.
J Clin Med. 2022 Apr 5;11(7):2039. doi: 10.3390/jcm11072039.
9
Androgen Deprivation Therapy in Patients with Prostate Cancer is Associated with the Risk of Subsequent Alzheimer's Disease but Not with Vascular Dementia.
World J Mens Health. 2022 Jul;40(3):481-489. doi: 10.5534/wjmh.210019. Epub 2021 Jun 29.
10
Reduced Cardiorespiratory Fitness and Increased Cardiovascular Mortality After Prolonged Androgen Deprivation Therapy for Prostate Cancer.
JACC CardioOncol. 2020 Nov 17;2(4):553-563. doi: 10.1016/j.jaccao.2020.08.011. eCollection 2020 Nov.
Zotero 插件